Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-costliest quintile among peers.
MFS Research International A MRSAX
- NAV / 1-Day Return 25.20 / +2.02 %
- Total Assets 16.9 Bil
-
Adj. Expense Ratio
- Expense Ratio 1.040%
- Distribution Fee Level Below Average
- Share Class Type Front Load
- Category Foreign Large Blend
- Investment Style Large Blend
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 1.34%
- Turnover 16%
USD | NAV as of Sep 26, 2024 | 1-Day Return as of Sep 26, 2024, 10:17 PM GMT+0
Morningstar’s Analysis MRSAX
Will MRSAX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 25.4
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Novo Nordisk AS Class B | 3.63 | 617.3 Mil | Healthcare |
Schneider Electric SE | 3.60 | 611.9 Mil | Industrials |
Linde PLC | 3.20 | 545.0 Mil | Basic Materials |
Roche Holding AG | 2.85 | 484.9 Mil | Healthcare |
ASML Holding NV | 2.31 | 393.4 Mil | Technology |
Hitachi Ltd | 2.30 | 391.0 Mil | Industrials |
Nestle SA | 2.26 | 384.1 Mil | Consumer Defensive |
Lvmh Moet Hennessy Louis Vuitton SE | 2.09 | 355.1 Mil | Consumer Cyclical |
TotalEnergies SE | 1.64 | 278.8 Mil | Energy |
NatWest Group PLC | 1.53 | 260.0 Mil | Financial Services |